Stockreport

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025   

Regen Biopharma, Inc. Common  (RGBP) 
NASDAQ:AMEX Investor Relations: regenbiopharmainc.com/investor-relations.html
PDF SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company will be presenting an update on [Read more]